DiscoverThe Craig Needles ShowLawson launches new study trialing BLES® as treatment for COVID-19
Lawson launches new study trialing BLES® as treatment for COVID-19

Lawson launches new study trialing BLES® as treatment for COVID-19

Update: 2020-07-07
Share

Description

Researchers at Lawson Health Research Institute are investigating the use of bovine lipid extract surfactant suspension (BLES®) for treating severe cases of COVID-19.


What is bovine lipid extract surfactant suspension and what can it do to help patients suffering from the disease caused by the novel coronavirus?


Dr. Jim Lewis, Lawson Scientist and Respirologist at St. Joseph’s Health Care London, joins Craig to discuss.

See omnystudio.com/listener for privacy information.

Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Lawson launches new study trialing BLES® as treatment for COVID-19

Lawson launches new study trialing BLES® as treatment for COVID-19

AM980 / Curiouscast